| Year |
Citation |
Score |
| 2022 |
Parker AL, Toulabi L, Oike T, Kanke Y, Patel D, Tada T, Taylor S, Beck JA, Bowman E, Reyzer ML, Butcher D, Kuhn S, Pauly GT, Krausz KW, Gonzalez FJ, ... ... Harris CC, et al. Creatine riboside is a cancer cell-derived metabolite associated with arginine auxotrophy. The Journal of Clinical Investigation. 132. PMID 35838048 DOI: 10.1172/JCI157410 |
0.304 |
|
| 2018 |
Greathouse KL, White JR, Vargas AJ, Bliskovsky VV, Beck JA, von Muhlinen N, Polley EC, Bowman ED, Khan MA, Robles AI, Cooks T, Ryan BM, Padgett N, Dzutsev AH, Trinchieri G, ... ... Harris CC, et al. Interaction between the microbiome and TP53 in human lung cancer. Genome Biology. 19: 123. PMID 30143034 DOI: 10.1186/S13059-018-1501-6 |
0.315 |
|
| 2017 |
Balatti V, Nigita G, Veneziano D, Drusco A, Stein GS, Messier TL, Farina NH, Lian JB, Tomasello L, Liu CG, Palamarchuk A, Hart JR, Bell C, Carosi M, Pescarmona E, ... ... Harris CC, et al. tsRNA signatures in cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 28696308 DOI: 10.1073/Pnas.1706908114 |
0.329 |
|
| 2014 |
Zhang Y, Calado R, Rao M, Hong JA, Meeker AK, Dumitriu B, Atay S, McCormick PJ, Garfield SH, Wangsa D, Padilla-Nash HM, Burkett S, Zhang M, Kunst TF, Peterson NR, ... ... Harris CC, et al. Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas. Plos One. 9: e101010. PMID 24983628 DOI: 10.1371/Journal.Pone.0101010 |
0.31 |
|
| 2014 |
Wang P, Zhou Z, Hu A, Ponte de Albuquerque C, Zhou Y, Hong L, Sierecki E, Ajiro M, Kruhlak M, Harris C, Guan KL, Zheng ZM, Newton AC, Sun P, Zhou H, et al. Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of Akt. Molecular Cell. 54: 378-91. PMID 24703948 DOI: 10.1016/J.Molcel.2014.03.007 |
0.355 |
|
| 2013 |
Tang Y, Horikawa I, Ajiro M, Robles AI, Fujita K, Mondal AM, Stauffer JK, Zheng ZM, Harris CC. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence. Oncogene. 32: 2792-8. PMID 22777358 DOI: 10.1038/onc.2012.288 |
0.385 |
|
| 2013 |
Okayama H, Saito M, Oue N, Weiss JM, Stauffer J, Takenoshita S, Wiltrout RH, Hussain SP, Harris CC. NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression. International Journal of Cancer. Journal International Du Cancer. 132: 9-18. PMID 22618808 DOI: 10.1002/ijc.27644 |
0.302 |
|
| 2011 |
Zhang C, Elkahloun AG, Robertson M, Gills JJ, Tsurutani J, Shih JH, Fukuoka J, Hollander MC, Harris CC, Travis WD, Jen J, Dennis PA. Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance. Plos One. 6: e23849. PMID 21887332 DOI: 10.1371/journal.pone.0023849 |
0.535 |
|
| 2009 |
Rudin CM, Avila-Tang E, Harris CC, Herman JG, Hirsch FR, Pao W, Schwartz AG, Vahakangas KH, Samet JM. Lung cancer in never smokers: molecular profiles and therapeutic implications. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5646-61. PMID 19755392 DOI: 10.1158/1078-0432.Ccr-09-0377 |
0.32 |
|
| 2009 |
Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, Koboldt DC, Fulton RS, Delehaunty KD, McGrath SD, Fulton LA, Locke DP, Magrini VJ, Abbott RM, Vickery TL, ... ... Harris CC, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. The New England Journal of Medicine. 361: 1058-66. PMID 19657110 DOI: 10.1056/Nejmoa0903840 |
0.32 |
|
| 2009 |
Kumamoto K, Fujita K, Kurotani R, Saito M, Unoki M, Hagiwara N, Shiga H, Bowman ED, Yanaihara N, Okamura S, Nagashima M, Miyamoto K, Takenoshita S, Yokota J, Harris CC. ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression. International Journal of Cancer. 125: 1306-15. PMID 19437536 DOI: 10.1002/ijc.24437 |
0.562 |
|
| 2009 |
Unoki M, Kumamoto K, Takenoshita S, Harris CC. Reviewing the current classification of inhibitor of growth family proteins. Cancer Science. 100: 1173-9. PMID 19432890 DOI: 10.1111/j.1349-7006.2009.01183.x |
0.301 |
|
| 2006 |
Okano T, Gemma A, Hosoya Y, Hosomi Y, Nara M, Kokubo Y, Yoshimura A, Shibuya M, Nagashima M, Harris CC, Kudoh S. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer. Oncology Reports. 15: 545-9. PMID 16465410 |
0.334 |
|
| 2004 |
West KA, Linnoila IR, Brognard J, Belinsky S, Harris C, Dennis PA. Tobacco carcinogen-induced cellular transformation increases Akt activation in vitro and in vivo. Chest. 125: 101S-2S. PMID 15136436 DOI: 10.1378/Chest.125.5_Suppl.101S |
0.494 |
|
| 2004 |
West KA, Linnoila IR, Belinsky SA, Harris CC, Dennis PA. Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo. Cancer Research. 64: 446-51. PMID 14744754 DOI: 10.1158/0008-5472.CAN-03-3241 |
0.539 |
|
| 2003 |
West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, Harris C, Belinsky S, Dennis PA. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. The Journal of Clinical Investigation. 111: 81-90. PMID 12511591 DOI: 10.1172/Jci16147 |
0.53 |
|
| 2002 |
Lechner JF, Wang Y, Siddiq F, Fugaro JM, Wali A, Lonardo F, Willey JC, Harris CC, Pass HI. Human lung cancer cells and tissues partially recapitulate the homeobox gene expression profile of embryonic lung. Lung Cancer (Amsterdam, Netherlands). 37: 41-7. PMID 12057866 |
0.312 |
|
| Show low-probability matches. |